Clinical trial
Itopride in Functional Dyspepsia:a Dose Finding Study
NCT00272103 · Royal Adelaide Hospital, Other · Completed
Key facts
| NCT number | NCT00272103 |
|---|---|
| Title | Itopride in Functional Dyspepsia:a Dose Finding Study |
| Official title | A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Dose Finding Study in 4 Parallel Groups to Establish the Efficacy and Safety of an Eight Week Treatment With Itopride Three Times Daily Compared to Placebo in Patients Suffering From Functional Dyspepsia |
| Lead sponsor | Royal Adelaide Hospital, Other |
| Collaborators | Knoll Pharmaceuticals, Germany (now Abbott) University Hospital, Essen |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Functional Dyspepsia |
| Intervention type | Drug |
| Interventions | Itopride (drug) |
| Enrollment | 500 |
| Start date | Dec 1, 2000 |
| Completion | Jan 1, 2002 |
| First posted | Jan 4, 2006 |
| Last update posted | May 4, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: